Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov:69:85-88.
doi: 10.1016/j.avsg.2020.07.013. Epub 2020 Jul 28.

Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19

Affiliations
Case Reports

Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19

Florian Veyre et al. Ann Vasc Surg. 2020 Nov.

Abstract

Introduction: Few cases of arterial thromboembolisms have been reported after novel coronavirus disease 2019 (COVID-19) in case of severe infection or in elderly patients. We report a case of femoral arterial thrombosis in a young patient after nonsevere infection.

Case description: A common femoral artery thrombosis extended in the first third of superficial and profunda femoral arteries associated with tibial posterior and popliteal artery thrombosis was diagnosed in a 24-year-old man complaining of right lower limb pain for one month. The evolution was good after anticoagulation and antiaggregant treatments and thrombectomy. Etiologic assessment was negative except for nonsevere COVID-19.

Discussion: COVID-19 accesses host cells via angiotensin-converting enzyme 2 protein, abundant in the lungs, which is also expressed by endothelial cells and is associated with important inflammatory syndrome and coagulopathy, leading to vascular lesions. Thrombosis prevalence is not fully established and seems to be higher in case of major inflammation and in the intensive care unit (ICU). Arterial thromboembolisms are described in many vascular territories, each time in elderly patients, or in case of severe infection. We described a femoral arterial thrombosis in a young patient with negative etiological assessment except nonsevere COVID-19. Treatment consists in anticoagulation and antiaggregant drugs and thrombectomy. Preventing venous thromboembolism treatment is recommended in case of severe infection or in the ICU, but there is no clear recommendation for arterial thromboembolism prevention. This case should lead us to be very careful of the arterial event risk even if the infection is nonsevere and the patient is young.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Three-dimensional CT arterial reconstruction showing common, superficial, and profunda femoral artery thrombosis (arrow) and the muscular artery allowing superficial femoral artery recanalization (arrowhead). (B) The histologic aspect of the collateral artery showing a fibrinocruoric thrombus without argument for septic etiology.

Comment in

  • Avascular Necrosis in Patients Recovering from COVID-19.
    Namiranian P, Razavi SZE, Karimi M, Ayati MH. Namiranian P, et al. Am J Med Sci. 2021 Sep;362(3):331-332. doi: 10.1016/j.amjms.2021.05.018. Epub 2021 May 24. Am J Med Sci. 2021. PMID: 34033806 Free PMC article. No abstract available.

References

    1. Sardu C., Gambardella J., Morelli M.B. Hypertension, thrombosis, Kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9:1417. - PMC - PubMed
    1. Varga Z., Flammer A.J., Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. - PMC - PubMed
    1. Ackermann M., Verleden S.E., Kuehnel M. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383:120–128. - PMC - PubMed
    1. Fogarty H., Townsend L., Ni Cheallaigh C. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020;189:1044–1049. - PMC - PubMed
    1. Bikdeli B., Madhavan M.V., Jimenez D. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020;75:2950–2973. - PMC - PubMed

Publication types

Substances